According to a recent press release from Cohera Medical, the company is about to begin (in November) human clinical trials in Europe of its TissuGlue (see link.) for use in abdominoplasty:
The feasibility study will investigate the safety and preliminary effectiveness of TissuGlu® and its effect on wound drainage and associated complications in abdominoplasty (tummytuck) surgeries. The study will be conducted at three sites near Bonn, Frankfurt, and Freiburg in Germany and will enroll 40 patients. Patient recruitment is expected to begin in November this year.
The use of tissue glue to adhere large tissue flaps in abdominoplasty is expected to avoid the problems with drains inserted at the surgical site to address accumulation of fluids underneath the flaps.
Cohera is hopeful, of course, that well demonstrated safety and effectiveness of TissueGlu for abdominoplasty will expand the caseload. Hundreds of thousands of abdominoplasties are performed annually in the United States.
TissuGlu and Cohera Medical are examined in "Worldwide Surgical Sealants, Glues and Wound Closure, 2009-2013", Report #S175, from MedMarket Diligence.